NDAQ vs STIM · P/E 41, rev $2.53B vs rev $76.0M
Nasdaq Inc (NDAQ) versus Neuronetics Inc (STIM) — a side-by-side from cached financials, not a winner call.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Neuronetics Inc (STIM) is a medical devices company listed on NASDAQ.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Latest reported STIM revenue for 2026-06-30 was $76.0M. Net income was -$14.2M. STIM currently screens at market cap $84.2M.
NDAQ currently screens at market cap $51.71B and trailing P/E 40.8. STIM currently screens at market cap $84.2M.
Not investment advice. Open the NDAQ and STIM stock pages for the full models.
Not investment advice.